HOME >> MEDICINE >> NEWS
Overactive bladder episodes completely controlled in 40 percent of elderly patients treated with once-a-day Oxybutynin

Elderly patients suffering from overactive bladder can significantly and safely reduce the symptoms of their condition by taking a once-a-day, extended-release formulation of oxybutynin chloride (Ditropan XL®), according to a study conducted by the Cleveland Clinic Foundation scheduled for presentation at the 2000 Annual Scientific Meeting of the American Geriatrics Society.

In the study, 40 percent of patients age 65 and older taking extended-release oxybutynin reported no incontinence episodes, while the average reduction in the weekly number of incontinence episodes for the elderly patients in the study was 82 percent.

"We found that elderly patients not only benefit by significantly reducing or eliminating their incontinence episodes when taking the extended-release formulation of oxybutynin, they also can do so safely and tolerate the drug very well. This is good news for this patient population, which frequently must deal with taking multiple medications and experiencing worrisome side effects," said Rodney Appell, M.D., study author and head, Section of Voiding Dysfunction and Female Urology at the Cleveland Clinic Urological Institute.

Overactive bladder is a common and chronic condition that affects an estimated 17 million Americans. The condition is characterized by urge urinary incontinence (sudden and involuntary loss of bladder control resulting in wetting accidents), urgency (the urgent need to empty the bladder) and frequency (frequent urination). Ditropan XL is the first and only once-a-day treatment for overactive bladder approved by the FDA and is marketed by ALZA Corporation and UCB Pharma.

For the study, investigators analyzed three clinical trials comparing different doses of extended-release and immediate-release oxybutynin in 159 patients older than 65 and in 261 patients age 18 to 65. All of the 420 patients suffered from overactive bladder.

During the clinical trials, researchers adjusted the
'"/>

Contact: Jim Armstrong, Cleveland Clinic
216-444-9455
Porter Novelli
19-May-2000


Page: 1 2 3

Related medicine news :

1. Overactive bladder symptoms affect sexual activity of women says Univ. of Pittsburgh study
2. New substance that improves the photodetection of bladder cancer gains market approval
3. Study examines three-day antibiotic regimens for treating bladder infection in women
4. New study tests amitriptyline for painful bladder syndrome
5. New test improves detection of bladder cancer
6. Faster, less expensive test proven more effective in detecting bladder cancer
7. Promise of bladder pacemaker for people with spinal cord injury
8. Use of estrogen therapy may increase risk for gallbladder disease
9. FDA approves Enablex for treatment of overactive bladder
10. Long-term data show benefit of DETROL LA as first-line therapy for overactive bladder
11. Scientists begin validation study of test to detect recurrence of bladder cancer

Post Your Comments:
(Date:7/24/2014)... 2014 Crawford Technologies today announced ... partnership with AIIM, focusing on global trends in ... of the survey indicated that even though organizations ... for customer service, legal and regulatory compliance and ... save exact facsimiles of these documents. , The ...
(Date:7/24/2014)... Freeslate, Inc ., the leading ... development, today announced its feature in the BioProcess ... Kling. Topics of this article include problematic ... automation can help address many of these problems. ... a growing focus of pharmaceutical organizations in recent ...
(Date:7/24/2014)... NE and Ft. Lauderdale, FL (PRWEB) July 24, ... an agreement to provide a wide range of ... nationwide. Under the agreement, BMG member practices can ... , “Blackmaple GroupPurchasing Solutions is growing rapidly, building ... Cooper, Partner. “Our approach is to offer deep ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 The discounts ... and beauty products do not include various skin creams ... now revealing skin tightening cream discounts inside of its ... The guide is now available to offer a direct ... recently released products available for sale. Although the guide ...
(Date:7/23/2014)... The age spots, wrinkles and puffy eyes that can be ... now explored in a new guide posted at the Cherry ... over 30 are introduced in the guide as well as ... of creams as an alternative to surgery is one method ... the information in the new guide. Because there are hundreds ...
Breaking Medicine News(10 mins):Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 4Health News:Freeslate Featured in BioProcess International Article Discussing Challenges and Solutions to Highly Concentrated Protein Formulations 2Health News:Freeslate Featured in BioProcess International Article Discussing Challenges and Solutions to Highly Concentrated Protein Formulations 3Health News:Seacoast Medical Partners with Blackmaple Group to Provide Members Cost Savings on Wide Range of Pharmaceutical Products 2Health News:Skin Tightening Cream Discounts Revealed in New Cost Saving Guide at Consumer Portal 2Health News:Best Eye Creams for Women Over 30 Detailed in Published Guide at News Website Online 2
(Date:7/24/2014)... 24, 2014   Cypher Genomics, Inc., ... agreement with Illumina to facilitate the development of ... precision medicine and clinical trials. Cypher Genomics and ... sales force, a solution including Illumina,s market leading ... and storage, and Cypher Genomics, biomarker discovery service, ...
(Date:7/24/2014)... --  ndd Medical Technologies , a leader in innovative ... announced that its EasyOne Pro ® has been ... Capacity (DLCO) for phase 2 of the COPDGene ® ... Pulmonary Disease (COPD) ever undertaken.  COPD is now the ... affects millions of people worldwide.  In ...
(Date:7/24/2014)... 24, 2014 Cognizant ... that it has been selected by ... with membership representation from 19 major pharmaceutical ... that will transform the way clinical sites ... TransCelerate BioPharma Inc. is dedicated to making ...
Breaking Medicine Technology:Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 2Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 3EasyOne Pro from ndd Medical Technologies Chosen Again as the Exclusive PFT Testing Technology in Phase 2 of COPDGene Study 2TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 2TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 3TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 4TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform 5
Cached News: